VEGFA and amyotrophic lateral sclerosis: Additionally, intramuscular injections of plasmids encoding multiple isoforms of hepatocyte growth factor (HGF, drug named VM202) or a transcription factor able to increase expression of vascular endothelial growth factor (VEGF, drug named SB-509) have been trialled in ALS patients (Scarrott et al., 2015).